Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
3.220
+0.080 (2.55%)
At close: Mar 6, 2026
9.15% (1Y)
| Market Cap | 4.78B |
| Revenue (ttm) | 7.32B |
| Net Income (ttm) | -85.17K |
| Shares Out | 1.48B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.01 (0.25%) |
| Ex-Dividend Date | n/a |
| Volume | 29,295,150 |
| Average Volume | 37,574,337 |
| Open | 3.120 |
| Previous Close | 3.140 |
| Day's Range | 3.110 - 3.220 |
| 52-Week Range | 2.510 - 4.690 |
| Beta | 0.36 |
| RSI | 44.44 |
| Earnings Date | Apr 23, 2026 |